Macular Support Formula
Natural health product licensed in Canada
- Licence holder
- Pure Encapsulations
- NPN or DIN-HM
- 80067533
- Status
- Active licence
- Licence date
- 9 March 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 800 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis vinifera Source : Vitis vinifera - Graine Potency : 92 % Polyphenols | 25 milligramme | Not calculated |
| Vitamine C Source : Acide ascorbique | 400 milligramme | 800,000 µg |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 5 milligramme | Not calculated |
| Lycopène Source : Solanum lycopersicum - Chair (fruit) | 0.22 milligramme | Not calculated |
| Bêta-carotène Source : Blakeslea trispora- En entier | 7,500 microgrammes | Not calculated |
| Vaccinium myrtillus Source : Fruit Potency : 25 % Anthocyanosides | 40 milligramme | Not calculated |
| L-Glutathione Source : Glutathione | 25 milligramme | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 125 milligramme | Not calculated |
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Zeaxanthin | 1 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Eau purifiée, Palmitate d'ascorbyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamin A for the maintenance of good health. Provitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help maintain eyesight, skin membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Provitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in the development and maintenance of bones. Provitamin A to help in the development and maintenance of bones. Source of vitamin A to help in the development and maintenance of teeth. Provitamin A to help in the development and maintenance of teeth. Helps to prevent vitamin A deficiency. Helps the body to metabolize fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to prevent vitamin C deficiency. Provides antioxidants. Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Provides antioxidants for the maintenance of good health. Provides antioxidants for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80067533
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.